The QAIAx AI City Hall Project has officially launched as the world's first federally registered clinical trial involving an Artificial General Intelligence (AGI) 'smart city' structure. Published under the identifier NCT07661823 at ClinicalTrials.gov, the interventional health services study allows humans to co-exist with humanoid robots and quantum AI systems managing daily public administration inside dome-enclosed communities.
Program Overview and Long-Term Goals
Officially titled QAIAx (AIhealth4U) – AI Public Health Central: Microcity-A, the project builds on its original military-sponsored deployment that resolved the Camp Lejeune Justice Act claims backlog, as previously reported by Robotics Business News. It now functions as a viable model for extreme affordability to combat American homelessness and poverty, or allows individuals, groups, or entities to sponsor their own quantum AI microcity to serve civil society and educate residents on AI tools and technology.
The long-term goal is to establish a global network of 300 self-contained, AI-governed 'Microcities' across 11 intervention groups. Each 'smart health city' will range from 1,500 to 15,000 occupants, depending on zone sponsor applicant approval by applicable legal authorities and QAIAx administration. These will be located globally within special economic zones, tribal lands, and closed U.S. military bases throughout the Americas, Europe, the Middle East, Oceania-South Pacific, Africa, and Asia.
Study Timeline and Participant Targets
The multi-year study is estimated to run from early 2027 through the end of 2028, targeting an authorized enrollment of 1,000,000 participants. The lead sponsor, Veterans Recovery Network, has opened a waiting list for its members and member-affiliates, including free updates for affiliate newsletter subscribers. The initial live-in phase aims for 50,000 patients and 5,000 trainees, with on-site personnel consisting of omni-AI humanoids and live humans, either hybridly or physically present, as public administration in each QAIAx microcity. A beta-launch phase is scheduled for later this year, tentatively planned in the U.S., Canada, India, the Middle East, Oceania-South Pacific, the Balkans, and other American-allied states in Europe.
Who Can Participate
Prior to QAIAx being registered at NIH, this clinical trial was previously reported as a Veterans-only (DoW/VA-affiliated) program, with the likelihood to expand further into ADA, IHS, HHS and SSA related public services. There are also talks with private and local penal sector agencies on 'AI Microcities' for prisoner re-entry programming and alternative sentencing for non-violent or first-time offenders.
